Basis: latest reported fiscal quarter (Q2 FY2026). Source: stored company filings; unavailable inputs remain N/A.
The latest quarterly revenue is $32.01M with QoQ Growth of +15.88%. Quarterly revenue is the total sales generated during the latest fiscal quarter.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $32.01M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T14:30:49.050Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T14:30:49.050Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
| Period | Quarterly Revenue | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $32.01M | +15.88% | +37.76% |
| Q1 FY2026Period end 2026-03-31 | $27.63M | (13.99%) | +56.62% |
| Q4 FY2025Period end 2025-12-31 | $32.12M | +17.86% | +57.15% |
| Q3 FY2025Period end 2025-09-30 | $27.25M | +17.28% | +63.14% |
| Q2 FY2025Period end 2025-06-30 | $23.24M | +31.74% | +54.45% |
| Q1 FY2025Period end 2025-03-31 | $17.64M | (13.70%) | +36.39% |
| Q4 FY2024Period end 2024-12-31 | $20.44M | +22.36% | +144.79% |
| Q3 FY2024Period end 2024-09-30 | $16.70M | +11.03% | +440.09% |
| Q2 FY2024Period end 2024-06-30 | $15.05M | +16.34% | N/A |
| Q1 FY2024Period end 2024-03-31 | $12.93M | +54.89% | N/A |
| Q4 FY2023Period end 2023-12-31 | $8.35M | +169.96% | N/A |
| Q3 FY2023Period end 2023-09-30 | $3.09M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
